The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades.
- DOI
- 10.1186/s13045-023-01409-5
- Published
- 2023 Mar 16
- Container
- Journal of hematology & oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13045-023-01409-5,
title = {The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades.},
author = {Jabbour E and Short NJ and Jain N and Haddad FG and Welch MA and Ravandi F and Kantarjian H},
year = {2023},
journal = {Journal of hematology \& oncology},
doi = {10.1186/s13045-023-01409-5},
url = {https://doi.org/10.1186/s13045-023-01409-5}
}RIS
TY - JOUR TI - The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades. AU - Jabbour E AU - Short NJ AU - Jain N AU - Haddad FG AU - Welch MA AU - Ravandi F AU - Kantarjian H PY - 2023 JO - Journal of hematology & oncology DO - 10.1186/s13045-023-01409-5 UR - https://doi.org/10.1186/s13045-023-01409-5 ER -
APA
E, J., NJ, S., N, J., FG, H., MA, W., F, R., & H, K. (2023). The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades.. Journal of hematology & oncology. https://doi.org/10.1186/s13045-023-01409-5
Source records
- pubmed · retrieved 2026-09-26T04:25:14.477Z